Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 14, 2003
GENELABS TECHNOLOGIES, INC.
California (State of Incorporation) | 0-19222 (Commission File No.) | 94-3010150 (IRS Employer Identification No.) |
505 Penobscot Drive, Redwood City, California 94063
(650) 369-9500
ITEM 7. EXHIBITS | ||||||||
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Table of Contents
ITEM 7. EXHIBITS
99.1 | Press Release of Registrant, dated November 14, 2003, entitled “Genelabs Technologies, Inc. Reports Third Quarter and Nine Month 2003 Financial Results.” |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On November 14, 2003, Genelabs Technologies, Inc., a California corporation (“Registrant”), announced its 2003 third quarter and nine month financial results. The text of the press release is furnished as Exhibit 99.1 to this Form 8-K.
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
GENELABS TECHNOLOGIES, INC. | ||||
By: | /s/ Matthew M. Loar | |||
Name: | Matthew M. Loar | |||
Title: | Chief Financial Officer | |||
Date: November 14, 2003 |
Table of Contents
EXHIBIT INDEX
EXHIBIT NO. | DESCRIPTION | |
99.1 | Press Release of Registrant, dated November 14, 2003, entitled “Genelabs Technologies, Inc. Reports Third Quarter and Nine Month 2003 Financial Results.” |